Table 1 Susceptibility and infectiousness profiles taken from Davies et al. [14], ONS reports and Viner et al. [16]
Study | Age groups | Susceptibility | Infectiousness | Clinical fraction |
|---|---|---|---|---|
Davies et al.a | 0–4 | 0.4 (0.25, 0.57) | 0.61 | 0.29 (0.18, 0.44) |
5–10 | 0.4 (0.25, 0.57) | 0.61 | 0.29 (0.18, 0.44) | |
11–17 | 0.4 (0.27, 0.53) | 0.61 | 0.21 (0.12, 0.31) | |
18–29 | 0.79 (0.59, 0.96) | 0.64 | 0.27 (0.18, 0.38) | |
30–39 | 0.86 (0.69, 0.98) | 0.67 | 0.33 (0.24, 0.43) | |
40–49 | 0.80 (0.61, 0.96) | 0.70 | 0.40 (0.28, 0.52) | |
50–59 | 0.82 (0.63, 0.97) | 0.75 | 0.49 (0.37, 0.60) | |
60–69 | 0.88 (0.70, 0.99) | 0.82 | 0.63 (0.49, 0.76) | |
70+ | 0.74 (0.56, 0.90) | 0.85 | 0.69 (0.57, 0.82) | |
ONSb | 0–4 | 0.5 (0.35, 0.75) | 1.0 (0.7, 1.5) | |
5–10 | 0.5 (0.35, 0.75) | 1.0 (0.7, 1.5) | ||
11–17 | 0.5 (0.35, 0.75) | 1.0 (0.7, 1.5) | ||
18–29 | 1.0 | 1.0 | ||
30–39 | 1.0 | 1.0 | ||
40–49 | 1.0 | 1.0 | ||
50–59 | 1.0 | 1.0 | ||
60–69 | 1.0 | 1.0 | ||
70+ | 1.0 | 1.0 | ||
Viner et al.c | 0–4 | 0.64 (0.51, 0.81) | 1.0 (assumed) | |
5–10 | 0.64 (0.51, 0.81) | 1.0 (assumed) | ||
11–17 | 0.64 (0.51, 0.81) | 1.0 (assumed) | ||
18–29 | 1.0 | 1.0 | ||
30–39 | 1.0 | 1.0 | ||
40–49 | 1.0 | 1.0 | ||
50–59 | 1.0 | 1.0 | ||
60–69 | 1.0 | 1.0 | ||
70+ | 1.0 | 1.0 | ||
CoMix fit | 0–4 | 0.31 (0.30, 0.31) | 1.0 | |
5–10 | 0.31 (0.30, 0.31) | 1.0 | ||
11–17 | 0.31 (0.30, 0.31) | 1.0 | ||
18–29 | 1.0 | 1.0 | ||
30–39 | 1.0 | 1.0 | ||
40–49 | 1.0 | 1.0 | ||
50–59 | 1.0 | 1.0 | ||
60–69 | 1.0 | 1.0 | ||
70+ | 1.0 | 1.0 |